Lung hyperinflation in COPD: the impact of pharmacotherapy

O'Donnell D. E., Laveneziana P.

Source: Eur Respir Rev 2006; 15: 85-89
Journal Issue: December 2006 - 15 (100)
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O'Donnell D. E., Laveneziana P.. Lung hyperinflation in COPD: the impact of pharmacotherapy. Eur Respir Rev 2006; 15: 85-89

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Physiology and consequences of lung hyperinflation in COPD
Source: Eur Respir Rev 2006; 15: 61-67
Year: 2006



Exercise and dyspnoea in COPD
Source: Eur Respir Rev 2006; 15: 72-79
Year: 2006



Dyspnoea
Source: Respipedia Article
Year: 2016

Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD
Source: Eur Respir J 2004; 23: 832-840
Year: 2004



Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 86-94
Year: 2004



Improving ventilatory mechanics
Source: Annual Congress 2005 - Contemporary physiological approaches to reversing the disease spiral in advanced COPD
Year: 2005

Mechanisms limiting exercise in COPD: new insights
Source: Annual Congress 2005 - Mechanical factors limiting physical exercise in disease
Year: 2005

Heliox, dyspnoea and exercise in COPD
Source: Eur Respir Rev 2009; 19: 30-38
Year: 2010



Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD
Source: Eur Respir J 2004; 24: 385-390
Year: 2004



Dynamic hyperinflation and pulmonary inflammation: a potentially relevant relationship?
Source: Eur Respir Rev 2006; 15: 68-71
Year: 2006



Evaluation of bronchodilator responses in patients with "irreversible" emphysema
Source: Eur Respir J 2001; 18: 914-920
Year: 2001



Nonpharmacological modulation of dynamic hyperinflation
Source: Eur Respir Rev 2006; 15: 90-96
Year: 2006



New strategies to improve exercise capacity in COPD
Source: Annual Congress 2006 - MP1 – New strategies to improve exercise capacity in COPD
Year: 2006

Lung hyperinflation, dyspnoe, and exercise tolerance in patients with COPD exacerbation
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010


Bronchodilator-induced changes in dynamic hyperinflation but not in airway obstruction are associated with improvement in dyspnoea in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 174s
Year: 2001

Impulse oscillation respiratory reactance and airway reversibility in chronic obstructive pulmonary disease
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015


Supplemental oxygen and heliox and dynamic hyperinflation during exercise
Source: Annual Congress 2006 - Management of dynamic hyperinflation during exercise in COPD
Year: 2006


NIV and pulmonary rehabilitation
Source: Eur Respir Mon; 2008: 41: 265–271
Year: 2008

Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD?
Source: Eur Respir J 2012; 40: 322-329
Year: 2012



Patterns of cardiopulmonary response to exercise in lung diseases
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-49-5, page=69
Year: 2007